Shahnaz Esmaeili
Overview
Explore the profile of Shahnaz Esmaeili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esmaeili S, Bandarian F, Razi F, Adibi H, Jalili A, Arjmand B, et al.
J Diabetes Metab Disord
. 2024 Nov;
23(2):1809-1816.
PMID: 39610497
Background: Endocrinology and Metabolism Research Institute (EMRI) is one of the biggest research institutes in Iran that was established to develop research strategies for managing endocrine and metabolic disorders such...
2.
Peimani M, Esfahani Z, Bandarian F, Esmaeili S, Moghaddam S, Namazi N, et al.
Iran J Public Health
. 2024 Oct;
53(4):913-923.
PMID: 39444467
Background: This study presents estimates for type 2 diabetes mellitus (T2DM) burden and attributable risk factors in Iran from 1990-2019, using data from the 2019 Global Burden of Disease study....
3.
Esmaeili B, Esmaeili S
Am J Med Sci
. 2024 Oct;
PMID: 39389358
According to reports, coronavirus disease 2019 (COVID-19) is associated with various complications, including hematological abnormalities. Lymphopenia and thrombocytopenia have been recognized as common hematological abnormalities. Moreover, some reports have shown...
4.
Namazi N, Moghaddam S, Esmaeili S, Peimani M, Tehrani Y, Bandarian F, et al.
BMC Public Health
. 2024 Jan;
24(1):98.
PMID: 38183083
Background: The prevalence of Type 2 Diabetes Mellitus (T2DM) in the North Africa and Middle East region is alarmingly high, prompting us to investigate the burden and factors contributing to...
5.
Bandarian F, Tehrani Y, Peimani M, Namazi N, Moghaddam S, Esmaeili S, et al.
Sci Rep
. 2023 Mar;
13(1):4210.
PMID: 36918650
The aim of the study was to report the burden of type one diabetes mellitus (T1DM) by sex, age, year, and province in Iran over the past 30 years, according...
6.
Esmaeili S, Bandarian F, Razi F, Namazi N, Esmaeili B, Sanjari M, et al.
J Diabetes Metab Disord
. 2022 Nov;
21(2):2017-2021.
PMID: 36404829
Background: A considerable amount of research funding goes to diabetes management strategies to improve therapeutic goals and reduce the burden of diabetes. A vast amount of the budget is wasted...
7.
Gharishvandi F, Moheimani H, Esmaeili S, Larijani B, Tootee A, Nasli Esfahani E, et al.
J Diabetes Metab Disord
. 2022 Nov;
21(2):1913-1921.
PMID: 36404822
Background: Proper synthesis of existing epidemiologic studies on diabetes in Iran can guide future research efforts. We aimed to conduct a comprehensive scoping review on all research articles that investigated...
8.
Bandarian F, Esmaeili S, Nasli-Esfahani E, Arjmand B, Larijani B
J Diabetes Metab Disord
. 2022 Jun;
21(1):1171-1176.
PMID: 35673473
Purpose: The study goal was to report research gaps in this field of diabetes complications in the past five years in Iran. Methods: All diabetes research outputs by Iranians from...
9.
Esmaeili S, Bandarian F, Gharishvandi F, Razi F, Hosseinkhani S, Namazi N, et al.
J Diabetes Metab Disord
. 2022 Jun;
21(1):1139-1148.
PMID: 35673463
Background: Mapping the available evidence can be used to inform current diabetes research, identify relevant gaps, and prioritize future research. In this regard, we mapped diabetes research performed in Iran....
10.
Esmaeili S, Moghaddam S, Namazi N, Bandarian F, Esfahani Z, Peimani M, et al.
Diabetes Res Clin Pract
. 2022 May;
188:109912.
PMID: 35537522
Aims: We aimed to report the burden of type 1 diabetes mellitus (T1DM) in the North Africa and Middle East region and its 21 countries from 1990 to 2019. Methods:...